Cargando…
Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model
BACKGROUND AND PURPOSE: cAMP and pharmacological inhibition of PDE4, which degrades it, are promising therapeutic targets for the treatment of spinal cord injury (SCI). Using our previously described in vitro SCI model, we studied the mechanisms by which cAMP modulators promote neurite outgrowth and...
Autores principales: | Boomkamp, S D, McGrath, M A, Houslay, M D, Barnett, S C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997278/ https://www.ncbi.nlm.nih.gov/pubmed/24467222 http://dx.doi.org/10.1111/bph.12588 |
Ejemplares similares
-
The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury
por: Schaal, Sandra Marie, et al.
Publicado: (2012) -
Epac1 interacts with importin β1 and controls neurite outgrowth independently of cAMP and Rap1
por: Baameur, Faiza, et al.
Publicado: (2016) -
The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury
por: Capuz, Alice, et al.
Publicado: (2022) -
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007) -
The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
por: Rutten, K., et al.
Publicado: (2007)